These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9414014)

  • 21. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
    Balla A; Sershen H; Serra M; Koneru R; Javitt DC
    Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
    J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-2 adrenoceptor activation inhibits phencyclidine-induced deficits of spatial working memory in rats.
    Marrs W; Kuperman J; Avedian T; Roth RH; Jentsch JD
    Neuropsychopharmacology; 2005 Aug; 30(8):1500-10. PubMed ID: 15714223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.
    Rouillon C; Abraini JH; David HN
    Exp Neurol; 2008 Jul; 212(1):213-7. PubMed ID: 18501353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.
    Drouin C; Blanc G; Villégier AS; Glowinski J; Tassin JP
    Synapse; 2002 Jan; 43(1):51-61. PubMed ID: 11746733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of beta-phenylethylamine on extracellular concentrations of dopamine in the nucleus accumbens and prefrontal cortex.
    Murata M; Katagiri N; Ishida K; Abe K; Ishikawa M; Utsunomiya I; Hoshi K; Miyamoto K; Taguchi K
    Brain Res; 2009 May; 1269():40-6. PubMed ID: 19285043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
    Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
    Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens.
    Del Arco A; Mora F; Mohammed AH; Fuxe K
    J Neural Transm (Vienna); 2007 Feb; 114(2):185-93. PubMed ID: 16897609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in responsiveness of mediodorsal thalamic and medial prefrontal cortical neurons to social interaction and systemically administered phencyclidine in rats.
    Jodo E; Katayama T; Okamoto M; Suzuki Y; Hoshino K; Kayama Y
    Neuroscience; 2010 Nov; 170(4):1153-64. PubMed ID: 20727386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study on the pharmacological action of phencyclidine].
    Ohmori T
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):205-13. PubMed ID: 8099562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia.
    Zuo D; Bzdega T; Olszewski RT; Moffett JR; Neale JH
    J Biol Chem; 2012 Jun; 287(26):21773-82. PubMed ID: 22570482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the adenosine A(1) receptor agonist N(6)-cyclopentyladenosine on phencyclidine-induced behavior and expression of the immediate-early genes in the discrete brain regions of rats.
    Gotoh L; Kawanami N; Nakahara T; Hondo H; Motomura K; Ohta E; Kanchiku I; Kuroki T; Hirano M; Uchimura H
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):1-12. PubMed ID: 12008016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.
    Adams B; Moghaddam B
    J Neurosci; 1998 Jul; 18(14):5545-54. PubMed ID: 9651235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966.
    Jentsch JD; Elsworth JD; Redmond DE; Roth RH
    J Neurosci; 1997 Mar; 17(5):1769-75. PubMed ID: 9030635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different roles of group I and group II metabotropic glutamate receptors on phencyclidine-induced dopamine release in the rat prefrontal cortex.
    Maeda J; Suhara T; Okauchi T; Semba J
    Neurosci Lett; 2003 Jan; 336(3):171-4. PubMed ID: 12505620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966.
    Jentsch JD; Andrusiak E; Tran A; Bowers MB; Roth RH
    Neuropsychopharmacology; 1997 Jun; 16(6):426-32. PubMed ID: 9165498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions.
    Noda Y; Kamei H; Mamiya T; Furukawa H; Nabeshima T
    Neuropsychopharmacology; 2000 Oct; 23(4):375-87. PubMed ID: 10989264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.
    Jentsch JD; Taylor JR; Roth RH
    Neuropsychopharmacology; 1998 Aug; 19(2):105-13. PubMed ID: 9629564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex.
    Rodrigues LC; Conti CL; Nakamura-Palacios EM
    Brain Res; 2011 Mar; 1382():230-7. PubMed ID: 21281616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.